Luis Rodriguez
lurod8.bsky.social
Luis Rodriguez
@lurod8.bsky.social
Molecular Biologist working on Lung Fibrosis
Reposted by Luis Rodriguez
Excited to help spread the word about the latest advances in stem cell research! #itsthecells!
Congratulations to BU's Darrel Kotton, MD, who has joined 12 other distinguished researchers on the editorial board for Stem Cell Reports, the official journal of the International Society for Stem Cell Research.
Stem Cell Reports welcomes new researchers to its Editorial Board. Their appointments reinforce the Board’s commitment to championing the journal, raising its global visibility, and ensuring rigorous, high-quality peer review. Read more: ow.ly/YicL50X5QJF
October 3, 2025 at 6:52 PM
Reposted by Luis Rodriguez
Announcing our latest publication, just out today
@NatureComms, advancing our understanding of interstitial lung disease. Congrats to co-senior authors Drs. Jeremy Katzen and Kostas Alysandratos and their teams @Penn @CReM_Boston. Check it out here: www.nature.com/articles/s41...
Aberrant intermediate alveolar epithelial cells promote pathogenic activation of lung fibroblasts in preclinical fibrosis models - Nature Communications
The direct contribution of aberrant epithelial cells to lung fibrosis is largely unknown. The authors use murine and human systems to identify how these cells activate fibroblasts, and how reciprocal signals cause them to enter a profibrotic state.
www.nature.com
September 30, 2025 at 10:14 PM
Check out the newest preprint from
the @westphillytough.bsky.social lead by @amurthy10.bsky.social exploring the important role of Regulatory T cells as modulators of fibrotic resolution! www.biorxiv.org/content/10.1...
REGULATORY T CELLS PROTECT AGAINST ABERRANT REMODELING IN A MOUSE MODEL OF PULMONARY FIBROSIS
Regulatory T (Treg) cells are well recognized for their role in immune regulation; however, their role in tissue regeneration is not fully understood. This study demonstrates such a role of Tregs in a published preclinical murine model of spontaneous pulmonary fibrosis (PF) expressing a human PF related mutation in the Surfactant Protein-C (SP-C) gene (SFTPCI73T). Genetic crosses of SP-CI73T mice with Foxp3GFP and Foxp3DTR lines were utilized to study Treg behavior during PF development. We found that FoxP3+Tregs accumulate during the transition from inflammation to fibrogenesis, peaking at 21-28 days after mutant SftpcI73T induction localizing to both perivascular and distal fibrotic lung regions. Diphtheria toxin mediated ablation of Tregs at 17 days worsened fibrosis and increased levels of TGFβ and inflammatory cytokines. Tregs expressed Th2 markers (Gata3+) and elaborated factors including amphiregulin (Areg) and Osteopontin (Spp1). Reductionist experiments showed that lung Tregs enhanced organoid formation when co-cultured with alveolar epithelial cells and adventitial fibroblasts, an effect size mimicked using Areg and Spp1 in combination. Our findings demonstrate that immune-mesenchymal-epithelial signaling crosstalk is present in the distal lung wherein Tregs play a protective role by limiting fibrosis and promoting tissue repair, highlighting their broader function beyond immune modulation in lung injury. ### Competing Interest Statement The authors have declared no competing interest. National Institutes of Health, https://ror.org/01cwqze88, 1R01HL145408, HL152970, HL007586, HL150226, 1K99HL171946
www.biorxiv.org
July 6, 2025 at 4:23 PM
Reposted by Luis Rodriguez
Truly amazing pluripotent stem cell clinical trial results for diabetes! “Off-the-shelf stem cell therapy for type 1 diabetes yields more positive results”. Also published in ⁦‪@NEJM‬⁩ this week. #helpisontheway!
www.statnews.com/2025/06/20/s...
Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results
An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.
www.statnews.com
June 21, 2025 at 3:30 AM
www.npr.org/sections/sho... Great story by NPR about this K99/R00 mass cancelation at the NIH
As a diversity grant dies, young scientists fear it will haunt their careers
The Trump administration defunded the National Institute of Health's MOSAIC grant program, which launched the careers of scientists from diverse backgrounds.
www.npr.org
April 28, 2025 at 5:13 PM